Objective:

To explore innovative strategies and emerging technologies for managing myopia, addressing the urgent need as its prevalence increases globally.

Key Findings:

• Ortho-k and multifocal soft lenses effectively slow myopia progression, supported by recent studies.
• Combination therapy with atropine and specialty lenses may improve treatment outcomes, as indicated by emerging research.
• Emerging technologies like biosensor-embedded lenses and AI-driven predictive algorithms could personalize myopia management, enhancing treatment efficacy.

Interpretation:

The integration of innovative therapies and technologies is crucial for advancing myopia management, emphasizing a shift towards personalized treatment plans that cater to individual patient needs.

Limitations:

• Need for more research on the long-term effects of combination therapies, particularly regarding patient outcomes.
• Complex engineering challenges, such as miniaturization and power supply, hinder the widespread adoption of smart contact lenses.
• Concerns regarding safety and efficacy of light-based therapies in children, necessitating further investigation.

Conclusion:

As research progresses, the combination of traditional and innovative approaches may redefine myopia management, leading to more effective and individualized care, underscoring the need for continued exploration in this field.